BRIDGEWAY CAPITAL MANAGEMENT, LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2018$20,0000.0%85,5000.0%0.00%
Q2 2018$20,000
-91.5%
85,500
-86.8%
0.00%
-100.0%
Q1 2018$234,000
+0.4%
649,8800.0%0.00%0.0%
Q4 2017$233,000
-13.7%
649,8800.0%0.00%0.0%
Q3 2017$270,000
-18.4%
649,8800.0%0.00%
-25.0%
Q2 2017$331,000
-11.7%
649,8800.0%0.00%
-20.0%
Q1 2017$375,000
-8.1%
649,8800.0%0.01%0.0%
Q4 2016$408,000
-31.4%
649,8800.0%0.01%
-44.4%
Q3 2016$595,000
+72.5%
649,8800.0%0.01%
+80.0%
Q2 2016$345,000
-43.8%
649,8800.0%0.01%
-50.0%
Q1 2016$614,000
-28.9%
649,8800.0%0.01%
-37.5%
Q4 2015$864,000
-41.7%
649,8800.0%0.02%
-48.4%
Q3 2015$1,482,000
+41.7%
649,8800.0%0.03%
+47.6%
Q2 2015$1,046,000
+1.3%
649,8800.0%0.02%0.0%
Q1 2015$1,033,000
-26.3%
649,880
-12.4%
0.02%
-34.4%
Q4 2014$1,402,000
+116.0%
741,780
+50.8%
0.03%
+100.0%
Q3 2014$649,000
-10.9%
491,7800.0%0.02%
-15.8%
Q2 2014$728,000
-17.4%
491,780
+3.3%
0.02%
-24.0%
Q1 2014$881,000475,9800.02%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2018
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders